Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DGAT1 inhibitors(Diacylglycerol O-acyltransferase 1 inhibitors), DGAT2 inhibitors(Diacylglycerol O-acyltransferase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H21N5O4 |
InChIKeyUKBQFBRPXKGJPY-INIZCTEOSA-N |
CAS Registry2186700-33-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Phase 2 | US | 21 Aug 2019 |